These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 33961968)

  • 1. Characterization of pregnancies exposed to St. John's wort and their outcomes: A claims data analysis.
    Schäfer W; Wentzell N; Schink T; Haug U
    Reprod Toxicol; 2021 Jun; 102():90-97. PubMed ID: 33961968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the safety of St. John's Wort in human pregnancy.
    Moretti ME; Maxson A; Hanna F; Koren G
    Reprod Toxicol; 2009 Jul; 28(1):96-9. PubMed ID: 19491000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
    Ng QX; Venkatanarayanan N; Ho CY
    J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
    Barnes J; Anderson LA; Phillipson JD
    J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of St John's wort in depression : what is known?
    Butterweck V
    CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interactions with St John's wort : mechanisms and clinical implications.
    Mannel M
    Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current St John's wort research from mode of action to clinical efficacy.
    Müller WE
    Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?
    Kholghi G; Arjmandi-Rad S; Zarrindast MR; Vaseghi S
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jun; 395(6):629-642. PubMed ID: 35294606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of serotonergic antidepressants and St John's wort in older Australians: a population-based cohort study.
    Rahman SZ; Basilakis J; Rahmadi A; Lujic S; Musgrave I; Jorm L; Hay P; Münch G
    Australas Psychiatry; 2013 Jun; 21(3):262-6. PubMed ID: 23439542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.
    Whiskey E; Werneke U; Taylor D
    Int Clin Psychopharmacol; 2001 Sep; 16(5):239-52. PubMed ID: 11552767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of St. John's wort (Hypericum perforatum) during breastfeeding.
    Lee A; Minhas R; Matsuda N; Lam M; Ito S
    J Clin Psychiatry; 2003 Aug; 64(8):966-8. PubMed ID: 12927015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. St John's wort (Hypericum perforatum) in major depression.
    Shelton RC
    J Clin Psychiatry; 2009; 70 Suppl 5():23-7. PubMed ID: 19909690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. St John's wort and depression: slight efficacy at best, many drug interactions.
    Prescrire Int; 2004 Oct; 13(73):187-92. PubMed ID: 15499702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort].
    Röder C; Schaefer M; Leucht S
    Fortschr Neurol Psychiatr; 2004 Jun; 72(6):330-43. PubMed ID: 15211398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants.
    Klier CM; Schmid-Siegel B; Schäfer MR; Lenz G; Saria A; Lee A; Zernig G
    J Clin Psychiatry; 2006 Feb; 67(2):305-9. PubMed ID: 16566628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
    Gelenberg AJ; Shelton RC; Crits-Christoph P; Keller MB; Dunner DL; Hirschfeld RM; Thase ME; Russell JM; Lydiard RB; Gallop RJ; Todd L; Hellerstein DJ; Goodnick PJ; Keitner GI; Stahl SM; Halbreich U; Hopkins HS
    J Clin Psychiatry; 2004 Aug; 65(8):1114-9. PubMed ID: 15323598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. St. John's wort.
    Lawvere S; Mahoney MC
    Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression.
    Solomon D; Adams J; Graves N
    J Affect Disord; 2013 Jun; 148(2-3):228-34. PubMed ID: 23291009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. St. John's wort: a new alternative for depression?
    Josey ES; Tackett RL
    Int J Clin Pharmacol Ther; 1999 Mar; 37(3):111-9. PubMed ID: 10190758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.